Join us for the second part of our series as Dr. John P. Overington and Dr. Molly Schmid delve deeper in to the drug discovery process. Tune in for a discussion on the big four druggable families and the difference between small molecule and biotherapeutic targets. John will also give an overview on the targets for currently launched drugs.
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
;void(0);){kind=link}